Executive Director Of Vaccine Formulation And Drug Product Development
Current
Mar 2024 - Present
AeroLeads people directory · profile
Chris Grainger Email & Phone Number
Executive Director for Vaccine Formulation and Drug Product Development at Vaxcyte
at
Vaxcyte
1 work email found
@vaxcyte.com
5 phones found area 858 and 415
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Executive Director for Vaccine Formulation and Drug Product Development at Vaxcyte
Location
San Mateo, California, United States
Who is Chris Grainger? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Chris Grainger is listed as Executive Director for Vaccine Formulation and Drug Product Development at Vaxcyte at Vaxcyte, based in San Mateo, California, United States. AeroLeads shows a work email signal at vaxcyte.com, phone signal with area code 858, 415, and a matched LinkedIn profile for Chris Grainger.
Chris Grainger previously worked as Executive Director of Vaccine Formulation and Drug Product Development at Vaxcyte and Senior Director of Vaccine Formulation and Drug Product Development at Vaxcyte. Chris Grainger holds Phd, Inhaled Toxicology And Permeability from King'S College London.
Company email context
Email format at Vaxcyte
This section adds company-level context without repeating Chris Grainger's masked contact details.
{first}.{last}@vaxcyte.com
86% confidence
AeroLeads found 1 current-domain work email signal for Chris Grainger. Compare company email patterns before reaching out.
Profile bio
About Chris Grainger
A highly skilled, energized and collaborative scientific project member and formulation lead, with 13 years in the vaccine industry within small, mid and large Pharma. One that is extremely comfortable working at all levels throughout an organization, with a central rule to success being open collaboration across and within the team working environment. Operates from core scientific principles to translate early vaccine research into viable process and product profiles for clinical and commercial use. • Experience working on the following classes of vaccine modalities for both prophylactic and therapeutic (cancer) targets: protein, peptide conjugate, polysaccharide conjugate, DNA, mRNA, adenoviral, AAV. • Experience of adjuvant systems: Alum, saponins, TLR agonists, CpG, Freud's, squalene. • Additional experience includes generation of delivery device for vaccine delivery by electroporation and buccal/slow release formulations. • Familiar with complex dosing schedules using varying vaccine modalities, small molecule and mAb biologicals, to generate either required Th1/Th2 immune responses through extensive pre-clinical research, moving into clinical assessments. To ensure appropriateness of all components of the Drug Product, extensive and novel analytical method development is performed within my teams, leading to characterization and an understanding of the stability of the individual components and final Drug Product.Summary: Specialized in the research and development of adjuvant formulations and Drug Product for novel and best-in-class vaccines in the research and clinical space.
Listed skills include Vaccines, Drug Development, Hplc, Cell Culture, and 17 others.
Current workplace
Chris Grainger's current company
Company context helps verify the profile and gives searchers a useful next step.
11 roles
Chris Grainger work experience
A career timeline built from the work history available for this profile.
Senior Director Of Vaccine Formulation And Drug Product Development
Mar 2022 - Mar 2024
Director Of Vaccine Formulation And Drug Product Development
Sep 2017 - Mar 2022
Senior Principal Scientist - Vaccine Formulation
Pfizer
Sep 2014 - Sep 2017
Principal Scientist - Vaccine Formulation
Pfizer
I led the Vaccine Research Formulation team developing early research and preclinical vaccine formulations on a numerous disease types. Vaccine modalities are both therapeutic and prophylactic, with a range of antigentic, adjuvant and delivery platforms under investigation.
Jan 2012 - Sep 2014
Senior Scientist - Vaccine Formulation
Pfizer
I worked within the Vaccine Research Formulation team in a small group developing early research and preclinical vaccine formulations on a numerous disease types. Vaccine modalities are both therapeutic and prophylactic, with a range of antigentic, adjuvant and delivery platforms under investigation.
Oct 2008 - Jan 2012
Senior Scientist - Inhaled Formulation
Pfizer
I worked as a lead formulation scientist in the development of dry powder inhaler products.
Oct 2007 - Oct 2008
Visiting Lecturer At King'S College London
Visiting lecturer at King's college London, giving annual lectures on basic vaccinology to the Pharmacy degree students
Mar 2009 - Mar 2009
Phd Researcher
The project was concerned with the development of a system to permit deposition of pharmaceutical and environmentally relevant aerosols onto a cell culture model of the bronchial epithelium. Toxicological endpoints and permeability of the cell layer after deposition of these particles were examined to give a better prediction of systemic exposure levels in vivo..
Mar 2003 - Mar 2007
Invited Scientist
I was invited to undertake a three month advisory position at MedImmune, CA. I was employed to build and develop a novel system of producing an inhaled vaccine of a monomodal particle size distribution for targeted delivery to the respiratory tract. Formulations using various spray drying conditions of live attenuated virus were produced to both allow virus viability and aerosolisation performance.
Jul 2006 - Oct 2006
Scientist
Quadrant Heathcare
Worked within a small team developing a live, inhalable measles vaccine via spray drying, in collaboration with the World Health Organisation. I was ultimately responsible for the design and production of the vaccine leading to testing in an primate model in Rotterdam, Netherlands. .
Apr 2001 - Jun 2003
2 education records
Chris Grainger education
Phd, Inhaled Toxicology And Permeability
King'S College London
Bsc, Microbiology
University Of Nottingham
FAQ
Frequently asked questions about Chris Grainger
Quick answers generated from the profile data available on this page.
What company does Chris Grainger work for?
Chris Grainger works for Vaxcyte.
What is Chris Grainger's role at Vaxcyte?
Chris Grainger is listed as Executive Director for Vaccine Formulation and Drug Product Development at Vaxcyte at Vaxcyte.
What is Chris Grainger's email address?
AeroLeads has found 1 work email signal at @vaxcyte.com for Chris Grainger at Vaxcyte.
What is Chris Grainger's phone number?
AeroLeads has found 5 phone signal(s) with area code 858, 415 for Chris Grainger at Vaxcyte.
Where is Chris Grainger based?
Chris Grainger is based in San Mateo, California, United States while working with Vaxcyte.
What companies has Chris Grainger worked for?
Chris Grainger has worked for Vaxcyte, Pfizer, King'S College London, Medimmune, and Quadrant Heathcare.
How can I contact Chris Grainger?
You can use AeroLeads to view verified contact signals for Chris Grainger at Vaxcyte, including work email, phone, and LinkedIn data when available.
What schools did Chris Grainger attend?
Chris Grainger holds Phd, Inhaled Toxicology And Permeability from King'S College London.
What skills is Chris Grainger known for?
Chris Grainger is listed with skills including Vaccines, Drug Development, Hplc, Cell Culture, Biotechnology, Molecular Biology, Pharmaceutical Industry, and In Vitro.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial